Combinostics logo — Using a combination of science and AI technology, we aim to...

Combinostics

Using a combination of science and AI technology, we aim to improve the lives of patients with neurological disorders.

Founded 2014 Finland Finland 11 employees Series A Total: $4.25M Enterprise Software, Health Care +2

General Information

Company Name Combinostics
Founded Year 2014
Location Finland Finland +1
Employees 11
Industries Enterprise Software, Health Care, Information Technology +1
Funding Stage Series A
Social

Get notified when Combinostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Combinostics

Combinostics, founded in 2014 and headquartered in Finland, is at the intersection of Enterprise Software, Health Care, Information Technology, and Robotics. The company is driven by its mission stated in its slogan: "Using a combination of science and AI technology, we aim to improve the lives of patients with neurological disorders." This sums up their focus on enhancing clinical decision-making with their flagship platform, cNeuro™. The technology leverages AI to integrate various data types—imaging biomarkers, demographic and clinical attributes, and neuropsychology test results—into actionable insights for clinicians.

Their latest funding round, a €3.90M Series A investment secured on 21 November 2019, involved notable support from Industrifonden and NordicNinja VC. This financial backing underscores investor confidence in Combinostics' potential for growth and impact within the neurological diagnostics landscape.

Taxonomy: AI Technology, Neurological Disorders, Clinical Decision Support, Diagnostic Tools, Medical Imaging, Imaging Biomarkers, Neuropsychology, Alzheimer's Disease, Patient Data Analytics, Healthcare Innovation, Evidence-Based Diagnostics, Digital Health Solutions, Clinical Diagnostics

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor Investor
21 Nov 2019
Non Equity Assistance •••••• 1
Investor
17 Dec 2018
Seed Round •••••• 1 •••• •••• 10 Mar 2017
Seed Round •••••• 1 •••• •••• 17 May 2016
Seed Round •••••• - 15 Dec 2014

Combinostics Alternatives & Competitors

Combinostics vs

ZS | Intomics is a highly specialized biomedical data analytics company. We derive core biological i...

Series Unknown
27 employees
Marketing
Combinostics vs
Orikami
Orikami The Netherlands

Orikami is a Dutch MedTech organization specialized in applying data science and developing digital...

Seed
20 employees
Analytics, Health Care
Combinostics vs
Quant Biomarkers
Quant Biomarkers Switzerland

Quant Biomarkers is a data-driven biomedical and longevitytech company.

5 employees
Biotechnology, Marketing

FAQ About Combinostics

Using a combination of science and AI technology, we aim to improve the lives of patients with neurological disorders.
Combinostics was founded in 2014.
Combinostics is headquartered in Finland.
Combinostics operates in the following industries: Enterprise Software, Health Care, Information Technology, Robotics.
Combinostics has approximately 11 employees.
Combinostics has completed 5 funding rounds, raising a total of $4.25M. The latest funding stage is Series A.
Top alternatives and competitors to Combinostics include ZS | Intomics, Orikami, Quant Biomarkers , VivoSense, Inc., Alto Neuroscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Combinostics and ZS | Intomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Combinostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy